| Product NDC: | 42002-200 |
| Proprietary Name: | Visine A |
| Non Proprietary Name: | Naphazoline Hydrochloride and Pheniramine Maleate |
| Active Ingredient(s): | .25; 3 mg/mL; mg/mL & nbsp; Naphazoline Hydrochloride and Pheniramine Maleate |
| Administration Route(s): | OPHTHALMIC |
| Dosage Form(s): | LIQUID |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 42002-200 |
| Labeler Name: | Johnson & Johnson Healthcare Products, Division of McNEIL-PPC, Inc. |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | NDA020485 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20101215 |
| Package NDC: | 42002-200-13 |
| Package Description: | 2 BOTTLE in 1 CARTON (42002-200-13) > 15 mL in 1 BOTTLE |
| NDC Code | 42002-200-13 |
| Proprietary Name | Visine A |
| Package Description | 2 BOTTLE in 1 CARTON (42002-200-13) > 15 mL in 1 BOTTLE |
| Product NDC | 42002-200 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | Naphazoline Hydrochloride and Pheniramine Maleate |
| Dosage Form Name | LIQUID |
| Route Name | OPHTHALMIC |
| Start Marketing Date | 20101215 |
| Marketing Category Name | NDA |
| Labeler Name | Johnson & Johnson Healthcare Products, Division of McNEIL-PPC, Inc. |
| Substance Name | NAPHAZOLINE HYDROCHLORIDE; PHENIRAMINE MALEATE |
| Strength Number | .25; 3 |
| Strength Unit | mg/mL; mg/mL |
| Pharmaceutical Classes |